Power of compounding intravitreal Bevacizumab - Experience from a tertiary eye care hospital

BACKGROUND: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. PURPOSE: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramesh, Santosh, Sivaranjani, S, Hasmukhbhai, Nirav Zala, Yadav, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
IJO Videos
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332976/
https://www.ncbi.nlm.nih.gov/pubmed/35502117
http://dx.doi.org/10.4103/ijo.IJO_1016_22
Descripción
Sumario:BACKGROUND: Bevacizumab vials that are commercially available are fractionated into smaller quantities into the form of pre-filled syringes in a sterile and aseptic laboratory setting. PURPOSE: To share the long term experience of aliquoting of bevacizumab injections in a tertiary eye care center in India. SYNOPSIS: Compounding of bevacizumab was found to be a cost-effective and sustainable practice that has benefited more patients with an affordable cost, while maintaining high levels of quality. HIGHLIGHTS: Compounding of bevacizumab, when done with aseptic precautions can be a safe and cost-effective practice, the benefits of which can be passed on to needful patients. VIDEO LINK: https://youtu.be/C5XOpKHFkew

Ejemplares similares